Pinealon Peptide: Complete Research Guide — Neuroprotective Mechanisms & Analysis
Shop Our Top Compounds
Pinealon Peptide Research: Complete Guide — Neuroprotective Mechanisms & Analysis
Meta Description: Pinealon peptide (EDR, Glu-Asp-Arg) is a synthetic tripeptide studied for neuroprotective and geroprotective properties. Explore the latest research findings.
Target Keywords: pinealon peptide, pinealon, EDR peptide, brain peptide research, neuroprotective peptides
All products mentioned in this article are sold strictly for laboratory and research purposes only. Not for human consumption. Consult applicable regulations in your jurisdiction before purchasing research materials.
Table of Contents
Origins of Pinealon: Khavinson Peptide Bioregulator Research
Pinealon vs. Epithalon: Comparing Two Khavinson Pineal Peptides
Quality Standards and Purity Verification for Research Peptides
What Is Pinealon Peptide?
Pinealon peptide is a synthetic tripeptide composed of three amino acid residues—glutamic acid, aspartic acid, and arginine (Glu-Asp-Arg)—commonly abbreviated as EDR using single-letter amino acid notation. With a molecular weight of approximately 418.4 Da, pinealon belongs to a class of ultrashort synthetic peptides, which are valued for their enhanced stability and use in research settings. These synthetic peptides are developed through decades of bioregulator research at the Saint Petersburg Institute of Bioregulation and Gerontology in Russia [1, 2].
The pinealon peptide was originally synthesized as a low-molecular-weight analog based on amino acid composition analysis of polypeptide complexes extracted from brain tissue. Despite its name suggesting an association with the pineal gland, pinealon’s primary research significance lies in its observed neuroprotective properties across multiple preclinical models [3, 4]. The EDR peptide has been the subject of peer-reviewed research spanning over two decades, with investigators exploring its potential roles in:
Neuroprotection against oxidative stress
Gene expression regulation in neuronal tissues
Dendritic spine preservation in neurodegenerative disease models
Serotonin synthesis modulation in brain cortex cells
Geroprotective (anti-aging) research at the cellular level
Researchers interested in exploring this compound for laboratory investigations can find high-purity Pinealon at Iron Peak Peptides, where all products are rigorously tested to ensure suitability for research applications.
As an ultrashort peptide consisting of just three amino acids, pinealon possesses several physicochemical characteristics that make it of particular interest to researchers studying neuroprotective peptides:
The compact size of the EDR peptide is a defining feature. Research suggests that ultrashort peptides of 2–4 amino acids in length, such as pinealon, may be capable of penetrating cell membranes and even interacting directly with the cell genome, potentially modulating gene expression through epigenetic mechanisms [5, 6]. This distinguishes them from larger peptides and proteins that typically require receptor-mediated signaling at the cell surface.
Pinealon is classified as a research peptide and is permitted for use in clinical research settings with appropriate oversight, but it is not approved for therapeutic use in the United States or by the European Medicines Agency.
The Science Behind Pinealon: Mechanism of Action
Understanding the mechanism of action of pinealon peptide requires examining multiple layers of molecular biology. Unlike many conventional pharmaceutical compounds that act through a single well-defined receptor pathway, the EDR peptide appears to operate through several interconnected mechanisms at the cellular and molecular level. Due to its small size, Pinealon can cross lipid bilayers, allowing it to penetrate both cellular and nuclear membranes. This unique property enables Pinealon to directly access intracellular targets and influence cellular processes beyond traditional receptor-mediated pathways. Notably, Pinealon has been shown to interact with the cell cycle, supporting neuroprotection and regeneration, particularly under oxidative stress or hypoxic conditions. Its neuroprotective mechanisms may involve cell cycle modulation, helping to offset neuronal damage without necessarily increasing cell numbers.
Cell Penetration and Nuclear Interaction
One of the most remarkable aspects of Khavinson’s ultrashort peptide research is the finding that short peptides like pinealon can penetrate cellular membranes and interact directly with DNA. Research conducted by Khavinson and colleagues demonstrated that the EDR peptide, due to its small size and specific charge distribution, may traverse cell membranes without requiring specialized transport proteins [5, 6].
Once inside the cell, molecular modeling studies have shown that the EDR peptide can bind to double-stranded DNA (dsDNA) in the minor groove of the B-form helix. The positively charged arginine (Arg+) residue at the C-terminus of the tripeptide plays a critical role in facilitating this DNA interaction, stabilizing the peptide-DNA complex through electrostatic interactions [7].
Gene Expression Regulation
The most well-documented mechanism of pinealon peptide action involves its potential capacity to regulate the expression of specific genes. Through molecular docking studies, Khavinson, Ilina, Linkova, and colleagues identified that the EDR peptide has binding sites in the promoter regions of several genes critically involved in neuronal function and neurodegeneration [7, 8]:
CASP3 — Caspase-3, a key enzyme in apoptotic pathways
NES — Nestin, a neural stem cell marker involved in neurogenesis
GAP43 — Growth-Associated Protein 43, essential for synaptic remodeling and memory formation
APOE — Apolipoprotein E, implicated in lipid transport and neurodegeneration
SOD2 — Superoxide Dismutase 2, a critical mitochondrial antioxidant enzyme
PPARA and PPARG — Peroxisome proliferator-activated receptors involved in anti-inflammatory and metabolic regulation
GPX1 — Glutathione Peroxidase 1, an antioxidant enzyme
Research suggests that by interacting with these gene promoter regions, the EDR peptide may exert epigenetic regulation—modulating whether these genes are transcribed into their protein products, ultimately influencing cell survival, antioxidant defense, and neuroplasticity [7, 8].
Antioxidant Defense Activation
A consistent finding across multiple studies is that pinealon appears to enhance cellular antioxidant defense systems. In vitro studies have demonstrated that the EDR peptide can suppress the accumulation of reactive oxygen species (ROS) in neuronal cell cultures exposed to oxidative stress [3, 4]. This antioxidant activity may be mediated, at least in part, through the peptide’s capacity to upregulate the expression of SOD2 and GPX1—two enzymes that form the first line of defense against oxidative damage in mitochondria and the cytosol [7].
Neurotransmitter Modulation
Studies published in the Bulletin of Experimental Biology and Medicine have demonstrated that the EDR peptide can stimulate serotonin expression in cerebral cortex cells [9]. This finding connects pinealon research to broader investigations into neurotransmitter regulation, circadian rhythm modulation, and mood-related neurochemistry—all areas where serotonin plays a foundational role.
Origins of Pinealon: Khavinson Peptide Bioregulator Research
The development of the pinealon peptide is inseparable from the broader program of peptide bioregulator research pioneered by Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology. This research tradition, spanning over 40 years, represents one of the most extensive bodies of work in the field of short peptide regulation of gene expression and aging. In addition to Pinealon, the Khavinson group has developed and studied peptides such as Epitalon, Thymalin, and Selank. There are also many other peptides currently under research for brain health, cognitive function, and neuroprotection, reflecting the expanding field of peptide research.
The Khavinson Bioregulator Paradigm
Beginning in the 1970s, Khavinson and his colleague V.G. Morozov developed a theoretical framework proposing that short peptides—consisting of 2 to 7 amino acid residues—serve as endogenous bioregulators capable of modulating gene expression in a tissue-specific manner [10, 11]. The initial work involved isolating polypeptide complexes from various animal organs, identifying their amino acid compositions, and then synthesizing the shortest peptides that could reproduce the biological activity of the full complex.
This approach yielded several peptide bioregulators, each named for its target organ:
Epithalon (AEDG) — Derived from pineal gland extracts, targeting telomerase and melatonin pathways
Pinealon (EDR) — Synthesized as a brain cortex peptide with neuroprotective properties
Vesugen (KED) — A vasoprotective peptide derived from vascular tissue
Thymalin — A thymic peptide complex for immune regulation
Cortexin — A polypeptide complex from cerebral cortex tissue
From Cortexin to Pinealon
Pinealon was identified as one of the short peptides present within the polypeptide complex Cortexin, a neuroprotective drug derived from cattle cerebral cortex tissue that has been used clinically in Russia for neurological conditions [7, 12]. The isolation and synthesis of pinealon represented an effort to identify the smallest active peptide component responsible for Cortexin’s neuroprotective effects.
Research has shown that the EDR peptide can reproduce several of the biological activities attributed to Cortexin, including neuroprotection against oxidative stress and promotion of neuronal viability, but with a far simpler molecular structure that allows for easier synthesis, higher purity, and more precise mechanistic study [7].
For researchers interested in exploring neuroprotective peptides from the Khavinson bioregulator tradition, Iron Peak Peptides offers both Pinealon and the related pineal peptide Epithalon, providing high-purity compounds suitable for controlled laboratory research.
Key Research Findings on Pinealon Peptide
The scientific literature on the EDR peptide encompasses in vitro cell culture studies, in vivo animal models, molecular modeling investigations, and preliminary clinical observations. Pinealon peptide research has demonstrated potential benefits for brain health, neuroprotection, and circadian rhythm regulation, making it a promising candidate for supporting cognitive function, cognitive performance—including mental clarity and working memory—and neurological wellness. As part of broader peptide research approaches, Pinealon is being studied alongside other neuroactive peptides for its role in cognitive and neurological health. Clinical studies have shown significant improvements in attention and memory tests with Pinealon supplementation. Below is a comprehensive review of the most significant research areas, organized by topic.
Neuroprotective Properties and Oxidative Stress Research
The foundational study establishing pinealon’s neuroprotective profile was published by Khavinson, Ribakova, Kulebiakin, and colleagues in Rejuvenation Research in 2011 [3]. This landmark investigation demonstrated that:
Free radical suppression: Pinealon significantly reduced intracellular reactive oxygen species (ROS) levels in multiple cell types, including cerebellar granule cells and PC-12 pheochromocytoma cells, when exposed to hydrogen peroxide (H₂O₂) or homocysteine-induced oxidative stress, with significant reductions observed in these studies.
Cell viability enhancement: The EDR peptide increased cell viability in neuronal cultures exposed to cytotoxic conditions, with effective concentrations reported to be considerably lower than those required for carnosine—a well-known endogenous neuroprotective dipeptide. Pinealon also reduces necrotic cell death and overall cell mortality in neuronal cultures.
Anti-apoptotic activity: Pinealon appeared to prevent apoptotic cell death in neurons exposed to oxidative insult, as measured by flow cytometry with propidium iodide staining. Pinealon has been shown to support neuronal resistance to hypoxic stress by stimulating innate antioxidant enzyme systems and limiting NMDA-induced excitotoxicity, which is implicated in neuronal death during traumatic brain injury and ischemic stroke. Notably, research indicates that Pinealon has been studied for its effects during oxygen deprivation, such as ischemic stroke, where it may influence caspase-3 activity to reduce apoptosis and cellular damage. This suggests Pinealon’s potential to disrupt the apoptotic pathway via caspase-3 modulation during ischemic events.
Proliferative stimulation: Beyond mere protective effects, the study reported that pinealon activated proliferative processes in certain cell populations, suggesting a role in tissue regeneration and repair pathways.
These findings positioned the pinealon peptide as a research compound of considerable interest for investigators studying oxidative stress-mediated neurodegeneration—a process implicated in virtually all neurodegenerative conditions.
Alzheimer’s Disease Models and Dendritic Spine Research
Some of the most compelling research on the EDR peptide involves its effects on dendritic spine morphology in Alzheimer’s disease (AD) models. In vitro studies, particularly those utilizing brain cortex cell cultures, have been used to examine Pinealon’s influence on neuronal health and dendritic spine morphology. Dendritic spines are the postsynaptic structures responsible for receiving synaptic input, and their loss is strongly correlated with cognitive decline in AD.
In Vitro Amyloid Synaptotoxicity Model
In hippocampal cell cultures treated with amyloid-beta 42 (Aβ42)—the toxic peptide fragment that accumulates in Alzheimer’s disease—the EDR peptide increased the number of mushroom spines (the stable, “memory” spines) by up to 71% compared to untreated controls [7, 8]. Mushroom spines are considered functionally the most important dendritic spine subtype because they contain the highest density of postsynaptic receptors and represent stable synaptic connections underlying long-term memory storage.
In Vivo 5xFAD Mouse Model
In a 2021 study published in Pharmaceuticals, Khavinson, Ilina, Kraskovskaya, Linkova, and colleagues conducted one of the most rigorous in vivo investigations of EDR peptide neuroprotection [8]. Using 5xFAD transgenic mice—a well-validated Alzheimer’s disease model carrying five familial AD mutations—the researchers found:
Daily intraperitoneal administration of the EDR peptide (400 μg/kg) from 2 to 4 months of age increased total dendritic spine density by 11% (p = 0.039) in CA1 hippocampal neurons compared to untreated 5xFAD mice.
In male 5xFAD mice, the EDR peptide restored dendritic spine density to control (wild-type) levels and increased mushroom spine numbers by 25% (p = 0.004).
The peptide exhibited sex-dependent neuroprotective effects: in male mice, it restored both spine density and mushroom spine numbers, while in females, it primarily restored total spine density.
The EDR peptide showed a bioregulatory rather than pharmacological action pattern—its effects were more pronounced where baseline pathology was more severe, suggesting a normalizing rather than stimulatory mechanism.
These findings suggest that the EDR peptide may help preserve the synaptic architecture that underlies memory and cognitive function in the context of amyloid pathology, a discovery with significant implications for brain peptide research.
Huntington’s Disease Models
The neuroprotective effects of pinealon extend beyond Alzheimer’s disease models. In a 2017 study, Khavinson, Linkova, Kukanova, and colleagues demonstrated that the EDR peptide restored the morphology of dendritic spines in medium spiny neurons (MSNs) of the striatum in a mouse model of Huntington’s disease (HD) [13].
In HD, MSN spine loss is a hallmark of the disease and correlates with the characteristic motor dysfunction. The study found that the EDR peptide:
Increased spine density in striatal neurons of HD model mice
Restored spine morphology toward normal patterns
Normalized behavioral responses in animal studies
These findings broadened the research scope of pinealon from a compound studied primarily in the context of AD to a more general neuroprotective peptide with potential relevance across multiple neurodegenerative conditions.
Prenatal Neuroprotection and Cognitive Function Research
A particularly notable area of pinealon research involves its effects in models of prenatal brain injury. In 2012, Arutjunyan, Kozina, Stvolinskiy, Bulygina, Mashkina, and Khavinson published a study in the International Journal of Clinical and Experimental Medicine examining pinealon’s effects on rat offspring exposed to prenatal hyperhomocysteinemia—a condition that causes oxidative stress damage to the developing brain [4].
Key findings included:
Improved spatial orientation and learning: Rat pups whose mothers received pinealon during methionine loading showed significantly better performance in the Morris water maze test compared to pups from mothers who received methionine alone.
Enhanced neuronal resistance to oxidative stress: Cerebellum neurons isolated from pinealon-treated offspring demonstrated significantly lower ROS accumulation and fewer necrotic cells when exposed to H₂O₂, indicating that pinealon helps protect neurons from oxidative and hypoxic stress.
Preserved birth weight: Offspring in the methionine+pinealon group maintained normal birth weight (25.03 ± 4.86 g), compared to the significantly reduced weight in the methionine-only group (17.86 ± 3.05 g).
Neuroprotective mechanism independence: Pinealon did not reduce blood homocysteine levels, indicating that its protective effects were mediated through direct neuroprotection rather than metabolic correction of hyperhomocysteinemia.
Mechanistically, pinealon may support neural differentiation and support cell proliferation in developing brain tissue, contributing to neuronal resilience and regeneration. These findings may also have relevance for preventing or slowing age-related cognitive decline by supporting neuronal resilience and cognitive function throughout the lifespan.
These results demonstrated that pinealon’s neuroprotective properties were effective in an in vivo developmental neurotoxicity model, with functional behavioral outcomes confirming the cellular-level observations.
Serotonin Synthesis and Neurotransmitter Regulation
In 2014, Khavinson, Linkova, Tarnovskaya, and Umnov published an important study in the Bulletin of Experimental Biology and Medicine demonstrating that the EDR peptide stimulated serotonin expression in cerebral cortex cells [9]. This research showed that:
Both EDR (pinealon) and KED (Vesugen) peptides epigenetically regulate serotonin synthesis in brain cortex tissue
The effect was attributed to the peptides’ capacity to modulate gene expression rather than direct neurotransmitter production
The authors concluded that these short peptides possess both neuro- and geroprotective properties through this neurotransmitter modulation pathway
Pinealon’s influence on neurotransmitter regulation, particularly serotonin synthesis, may contribute to improved mental clarity and cognitive enhancement by supporting optimal brain function and neuroendocrine balance.
This finding connects pinealon research to the broader field of circadian rhythm regulation, as serotonin serves as the metabolic precursor to melatonin in the pineal gland. The observation that the EDR peptide can influence serotonin synthesis provides a potential mechanistic link between pinealon and pineal gland function, despite the peptide not being directly derived from pineal tissue.
Epigenetic Mechanisms and Gene Expression Regulation
The most mechanistically detailed research on pinealon involves its potential epigenetic effects. A comprehensive 2022 review by Ilina, Khavinson, Linkova, and Petukhov in the International Journal of Molecular Sciences analyzed the neuroepigenetic mechanisms of action of ultrashort peptides, with particular focus on the EDR peptide [14].
Key findings from this review include:
CALM1 gene regulation: The EDR peptide was found to have binding sites in the promoter of the CALM1 (calmodulin 1) gene. Calmodulin is the principal calcium-binding protein in the brain and plays a central role in calcium signaling, synaptic plasticity, and memory formation. Dysregulation of calmodulin-dependent signaling is implicated in Alzheimer’s disease pathogenesis.
DNA binding specificity: Molecular docking studies revealed that the EDR peptide preferentially binds to dsDNA sequences with higher GC content, with the positively charged Arg+ residue anchoring the peptide in the minor groove of the DNA double helix.
Cross-species conservation: The DNA-binding patterns and gene regulatory effects of EDR peptide were found to be consistent across multiple species, suggesting an evolutionarily conserved mechanism of action.
Influence on cellular processes: Pinealon’s epigenetic effects extend to the modulation of key cellular processes, including cell proliferation, by regulating gene expression involved in cellular health, tissue regeneration, and neuroprotection.
This body of research positions the pinealon peptide as a compound operating at the interface of epigenetics and neurodegeneration—a frontier area that may ultimately yield new insights into how short peptides regulate fundamental biological processes.
For researchers investigating neuroprotective peptides and their mechanisms, Iron Peak Peptides also provides Selank, another well-studied neuroprotective peptide that operates through complementary mechanisms and can be used in comparative studies alongside Pinealon.
Pinealon in Current Scientific Literature
The research landscape for the pinealon peptide continues to evolve. Recent publications have expanded the understanding of EDR peptide mechanisms in several important directions. Notably, ongoing studies suggest that Pinealon and related peptides may exhibit anabolic impacts in both neural and muscle cells, supporting cellular resilience and anti-aging effects through modulation of processes such as irisin expression, fat oxidation, and telomere maintenance. Additionally, Pinealon and similar bio-regulating peptides may contribute to reduced occupational risk by enhancing resistance to stress and supporting neurological resilience in demanding work environments.
Recent Developments (2020–Present)
Comprehensive gene expression review (2021): Khavinson and Popovich published a systematic review in Molecules analyzing how short peptides regulate gene expression across diverse organisms [15]. This work placed the EDR peptide within a broader theoretical framework, proposing that ultrashort peptides represent an ancient and evolutionarily conserved signaling system that predates the development of classical hormone and receptor pathways.
In vivo Alzheimer’s model confirmation (2021): The landmark 5xFAD mouse study by Khavinson, Ilina, and colleagues provided the strongest in vivo evidence to date for the neuroprotective efficacy of the EDR peptide, confirming earlier in vitro findings in a well-validated transgenic animal model [8].
Neuroepigenetic mechanisms review (2022): The comprehensive review by Ilina et al. in International Journal of Molecular Sciences integrated the available data on EDR peptide mechanisms into a unified model of neuroepigenetic regulation in Alzheimer’s disease [14].
Fibroblast-derived induced neuron studies (2024): Recent work from the Khavinson group has extended EDR peptide research into induced neuron models derived from fibroblasts, exploring how short peptides protect against age-related neuronal changes and stimulate dendritogenesis in these cutting-edge cellular systems [16].
Ongoing Research Directions
Current research on the EDR peptide is moving in several promising directions:
Blood-brain barrier penetration: Investigators are studying whether the EDR tripeptide can cross the blood-brain barrier, with preliminary evidence from analog peptides and the observed in vivo neuroprotective effects suggesting this may be the case [8].
Combination studies: Research is exploring the combined effects of EDR (pinealon) and KED (Vesugen) peptides, as both have demonstrated neuroprotective properties through partially overlapping but distinct mechanisms.
Chromatin remodeling: Advanced studies are investigating how EDR peptide interactions with DNA may influence chromatin structure and accessibility, potentially revealing new epigenetic regulatory mechanisms.
Circadian rhythm connections: Given pinealon’s effects on serotonin synthesis and its nominal association with pineal function, researchers are exploring whether EDR peptide administration can modulate circadian-related gene expression.
In the context of anti-aging and metabolic research, Pinealon has been linked to elevated levels of irisin, a peptide involved in neural differentiation and proliferation, which may enhance overall neuronal function and cognitive health. Ongoing studies are also examining how Pinealon may influence fat oxidation and plasma irisin levels, both of which are associated with telomere length and cellular aging processes. Additionally, calorie restriction is a well-established intervention for extending cellular lifespan, and Pinealon research is exploring similar pathways related to telomere maintenance and biomarkers of cellular health.
Pinealon vs. Epithalon: Comparing Two Khavinson Pineal Peptides
Researchers frequently compare two peptides from the Khavinson bioregulator program that both relate to pineal gland research: Pinealon (EDR) and Epithalon (AEDG). While both emerged from the same research tradition and share connections to brain and aging research, they are distinct molecules with different structures, targets, and research profiles. Notably, Pinealon’s neuroprotective and anti-aging effects are particularly relevant to the central nervous system and brain function, with research suggesting it may slow cellular aging in neural tissues.
Feature | Pinealon (EDR) | Epithalon (AEDG) |
|---|---|---|
Sequence | Glu-Asp-Arg | Ala-Glu-Asp-Gly |
Length | Tripeptide (3 aa) | Tetrapeptide (4 aa) |
Molecular Weight | ~418 Da | ~390 Da |
Derived From | Brain cortex tissue analysis | Pineal gland extract (Epithalamin) |
Primary Research Focus | Neuroprotection, gene expression regulation | Telomerase activation, melatonin synthesis |
Key Mechanism | DNA binding in gene promoters, antioxidant defense | Telomere elongation, pineal gland function |
Neurodegenerative Research | Extensive (AD, HD models) | Limited |
Aging/Longevity Research | Moderate | Extensive |
Serotonin/Melatonin | Stimulates serotonin synthesis in cortex cells | Stimulates melatonin synthesis in pineal gland |
Complementary Research Applications
Epithalon (AEDG) was synthesized based on the amino acid composition of Epithalamin, a polypeptide extract from the pineal gland. Its primary research significance lies in its reported capacity to induce telomerase activity, elongate telomeres, and stimulate melatonin production—effects that position it as a compound of interest in aging and longevity research [17, 18].
Pinealon (EDR), by contrast, emerged from brain cortex tissue research and has been studied primarily for its neuroprotective properties—preserving dendritic spines, reducing oxidative stress, and regulating the expression of genes involved in neurodegeneration.
Despite their different primary research applications, both peptides share the Khavinson paradigm of short peptide bioregulation and may have complementary effects in aging research contexts. Researchers interested in exploring both compounds can find Epithalon alongside Pinealon at Iron Peak Peptides.
The Role of the Pineal Gland in Brain Peptide Research
To fully appreciate the research context of the pinealon peptide, it is valuable to understand the pineal gland’s role in neuroscience and aging research. The pineal gland is central to regulating circadian rhythms, which govern the sleep-wake cycle and influence various physiological processes. Pinealon peptide has been studied for its potential to address circadian rhythm disturbances, improve sleep quality, and support circadian rhythm regulation. These effects may also extend to supporting cardiovascular function, as proper circadian regulation is linked to biosystem stability and blood pressure control. Notably, Pinealon peptide may assist in mitigating dysfunctions arising from activities such as shift work or long-distance travel, which disrupt normal sleep patterns.
Pineal Gland Function and Aging
The pineal gland is a small endocrine organ located in the epithalamus of the brain. Its primary known function is the production of melatonin, a hormone that regulates circadian rhythms, possesses antioxidant properties, and plays roles in immune modulation and neuroprotection [19, 20].
Age-related changes in pineal gland function are well-documented:
Melatonin production declines progressively with age
Calcification of pineal tissue increases with aging
Circadian rhythm disruption becomes more common in elderly populations
Antioxidant capacity diminishes as melatonin output decreases
The Khavinson Pineal Research Program
Khavinson’s research group has studied pineal gland aging extensively. Their work demonstrated that peptide preparations derived from the pineal gland (Epithalamin and its synthetic analog Epithalon) could restore melatonin synthesis in aged animals and potentially extend lifespan in experimental models [17, 18, 19].
While pinealon was not directly derived from pineal tissue, its research connections to the pineal gland are multifaceted:
Serotonin modulation: The EDR peptide’s demonstrated ability to stimulate serotonin synthesis in cortex cells [9] connects it to melatonin production, as serotonin is the biosynthetic precursor to melatonin.
Neuroprotective overlap: Both pinealon and pineal-derived peptides show neuroprotective properties, potentially through shared antioxidant mechanisms.
Geroprotective context: Both compounds are studied within the broader framework of peptide-mediated geroprotection—the use of peptides to counteract age-related functional decline.
Quality Standards and Purity Verification for Research Peptides
The integrity of research using the pinealon peptide depends critically on the quality and purity of the compound used. Given pinealon’s short sequence (only three amino acids), even trace impurities or synthetic errors can dramatically alter experimental outcomes.
Critical Quality Parameters
Researchers should ensure that their pinealon source meets the following standards:
Purity ≥98% (preferably high quality): Verified by High-Performance Liquid Chromatography (HPLC), which separates the target peptide from synthesis byproducts, truncated sequences, and other impurities.
Correct molecular weight confirmation: Verified by Mass Spectrometry (MS), typically electrospray ionization mass spectrometry (ESI-MS) or matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF).
Proper amino acid sequence verification: Confirmed by amino acid analysis or tandem mass spectrometry (MS/MS) to ensure the correct Glu-Asp-Arg sequence.
Endotoxin testing: For cell culture and in vivo research, peptides should be tested for bacterial endotoxin contamination using the Limulus Amebocyte Lysate (LAL) assay.
Sterility verification: For injectable research applications, sterility testing per USP standards should be documented.
quality assurance. Learn more about available research compounds at buy research peptides in the USA.
How to Evaluate Pinealon Peptide Quality for Research
When sourcing pinealon peptide for laboratory investigations, researchers should apply systematic quality evaluation criteria. Not all peptide suppliers maintain the same manufacturing standards, and the consequences of using substandard material can range from irreproducible results to completely invalid experimental conclusions.
Key Evaluation Criteria
1. Manufacturing Standards
Does the supplier manufacture under GMP (Good Manufacturing Practice) or ISO-certified conditions?
Is the synthesis facility registered and inspectable?
Are clean room conditions maintained during handling and packaging?
2. Analytical Documentation
Is a batch-specific quality assurance provided?
Are HPLC chromatograms included (not just purity numbers)?
Is mass spectrometry data available for molecular weight confirmation?
3. Third-Party Verification
Does the supplier use established laboratories for quality testing?
Are testing laboratories accredited (e.g., ISO 17025)?
4. Consistency and Reliability
Does the supplier demonstrate batch-to-batch consistency?
Are historical CoAs available for comparison?
Is there a formal quality control and quality assurance program?
5. Proper Handling and Shipping
Are peptides shipped with appropriate cold chain protection?
Is desiccant included to prevent moisture degradation?
Are containers properly sealed and labeled?
Red Flags to Avoid
Researchers should exercise caution with suppliers that:
Cannot provide a quality assurance
List purity claims without supporting analytical data
Offer unusually low prices that suggest compromised quality
Have no verifiable manufacturing or business address
Cannot answer technical questions about their synthesis process
Comparing Pinealon Sources: What Sets IronPeak Apart
In the competitive landscape of research peptide suppliers, Iron Peak Peptides has established a reputation for providing consistently high-quality compounds that meet the exacting standards required for rigorous scientific research.
Iron Peak Peptides Quality Commitment
Iron Peak Peptides differentiates itself through several key quality practices:
high quality standard: Every batch of Pinealon is verified by HPLC to meet or exceed high quality.
Third-party testing: Independent laboratory verification ensures that quality claims are objective and verifiable.
Complete documentation: Every order includes a detailed quality assurance with full analytical data.
Proper cold chain shipping: Temperature-sensitive peptides are shipped with appropriate cold packs and insulation to maintain stability.
Expert support: The IronPeak team includes specialists who can assist with technical questions about peptide handling, storage, and reconstitution for research applications.
Broad product range: In addition to Pinealon, researchers can access a comprehensive peptide catalog including complementary compounds for comparative studies.
For researchers seeking to understand peptide terminology and classifications, the IronPeak Peptide Glossary provides a valuable educational resource.
Proper Storage and Handling of Pinealon for Research Use
Proper storage and handling of the pinealon peptide are essential for maintaining compound integrity and ensuring reproducible research results. As a short peptide, pinealon is relatively stable compared to larger proteins, but appropriate precautions are still necessary. In research settings, Pinealon is often administered via subcutaneous injection; proper technique, site rotation, and sterile procedures are essential for safety and efficacy.
Lyophilized (Powder) Storage
Pinealon is typically supplied as a lyophilized (freeze-dried) powder. In this form, it offers the greatest stability:
Long-term storage: Store at -20°C or below in a sealed container with desiccant
Medium-term storage: Stable at 2–8°C for several months when kept dry
Room temperature: Acceptable for short periods during handling, but minimize exposure
Light protection: Store in amber or opaque containers; avoid prolonged exposure to direct light
Moisture protection: Keep sealed with desiccant; moisture is the primary degradation factor for lyophilized peptides
Reconstitution Guidelines for Research
When preparing pinealon solutions for research applications:
Solvent selection: Pinealon is water-soluble due to its charged amino acid residues. Reconstitution in sterile distilled water, physiological saline (0.9% NaCl), or appropriate buffer (e.g., PBS at pH 7.4) is generally suitable.
Reconstitution technique: Add solvent slowly down the side of the vial to avoid excessive foaming. Gently swirl (do not vortex vigorously) until fully dissolved.
Concentration: Prepare at appropriate concentration for your experimental protocol. The studies reviewed in this article used concentrations ranging from nanomolar to micromolar ranges for in vitro work, and doses of 10–400 μg/kg for in vivo research [3, 4, 8].
Filtration: For cell culture applications, filter reconstituted solutions through a 0.22 μm sterile syringe filter.
Reconstituted Solution Storage
Short-term (days): Store at 2–8°C
Medium-term (weeks): Aliquot and store at -20°C to avoid repeated freeze-thaw cycles
Long-term: Not recommended; prepare fresh solutions when possible
Freeze-thaw: Minimize freeze-thaw cycles; aliquot reconstituted peptide into single-use volumes
Handling Best Practices
Practice | Recommendation |
|---|---|
Gloves | Always wear nitrile gloves when handling |
Work surface | Use a clean, designated peptide handling area |
Weighing | Use an analytical balance (0.1 mg precision) |
Static | Use anti-static tools; lyophilized peptides can carry charge |
Documentation | Record lot number, reconstitution date, concentration, and storage conditions |
Frequently Asked Questions About Pinealon Peptide
What is Pinealon peptide and what is it used for in research?
Pinealon peptide (Glu-Asp-Arg, or EDR) is a synthetic tripeptide bioregulator developed by the Khavinson research group at the Saint Petersburg Institute of Bioregulation and Gerontology. In the research context, it is used to study neuroprotective mechanisms, gene expression regulation, dendritic spine preservation, antioxidant defense pathways, and epigenetic modulation in neuronal cell cultures and animal models of neurodegenerative disease. Pinealon is classified as a research compound and is sold strictly for laboratory and research purposes only.
How does the EDR peptide differ from other neuroprotective peptides?
The EDR peptide is distinguished by its ultrashort length (just three amino acids), its proposed ability to penetrate cell membranes and interact directly with DNA, and its demonstrated capacity to modulate the expression of multiple genes simultaneously—including CASP3, NES, GAP43, APOE, SOD2, PPARA, PPARG, and GPX1 [7, 8]. Unlike many neuroprotective compounds that act through single receptor pathways, pinealon appears to operate through a multi-target epigenetic mechanism, potentially regulating dozens of genes involved in neuronal survival, antioxidant defense, and synaptic plasticity.
What is the relationship between Pinealon and the pineal gland?
Despite its name, Pinealon was not directly derived from pineal gland tissue. It was synthesized based on amino acid analysis of brain cortex polypeptide complexes. However, research has established functional connections between pinealon and pineal-related pathways, particularly through its demonstrated ability to stimulate serotonin expression in cerebral cortex cells [9]. Since serotonin is the biosynthetic precursor to melatonin (the primary hormone produced by the pineal gland), pinealon research intersects with pineal gland function research at the neurotransmitter level.
What research models have been used to study Pinealon?
Pinealon has been studied in a diverse range of preclinical models, including: cerebellar granule cell cultures, PC-12 pheochromocytoma cell lines, primary hippocampal neuronal cultures, cortico-striatal neuronal co-cultures, human dental stem cells, prenatal hyperhomocysteinemia rat models (in vivo), 5xFAD transgenic Alzheimer’s disease mouse models (in vivo), Huntington’s disease mouse models, fibroblast-derived induced neuron models, and myocardial infarction models where its potential to reduce caspase-3 expression and apoptosis after cardiac events has been evaluated [3, 4, 7, 8, 13, 16]. This breadth of experimental systems provides converging evidence for pinealon’s neuroprotective properties.
How does Pinealon compare to Epithalon in research applications?
Pinealon (EDR) and Epithalon (AEDG) are both Khavinson peptide bioregulators, but they have different primary research applications. Pinealon is primarily studied for neuroprotection—preserving dendritic spines, reducing oxidative stress, and regulating neuronal gene expression. Epithalon is primarily studied for its effects on telomerase activation, telomere elongation, and melatonin synthesis stimulation. While both peptides have connections to aging research, Pinealon’s research profile is more focused on neurodegenerative disease models, whereas Epithalon’s research profile emphasizes longevity and endocrine aging [7, 8, 17, 18].
What purity level is recommended for Pinealon research?
For rigorous scientific research, a purity level of ≥98% (and preferably high quality) as verified by HPLC is recommended. This standard ensures that observed biological effects can be attributed to the EDR peptide itself rather than synthesis impurities. Additionally, mass spectrometry confirmation of the correct molecular weight and amino acid sequence verification are important quality controls. Iron Peak Peptides provides Pinealon meeting these stringent purity standards, with full quality assurance documentation for each batch.
What are the storage requirements for Pinealon peptide?
Lyophilized Pinealon should be stored at -20°C or below for long-term preservation, protected from moisture and light. The lyophilized form is highly stable under these conditions. Once reconstituted in aqueous solution, Pinealon should be aliquoted into single-use volumes and stored at -20°C, with freeze-thaw cycles minimized. Reconstituted solutions stored at 2–8°C should be used within days. Always use sterile technique when reconstituting peptides intended for cell culture research.
What genes has Pinealon been shown to potentially regulate?
Molecular docking and gene expression studies have identified binding sites for the EDR peptide in the promoter regions of several genes critical to neuronal function: CASP3 (caspase-3, involved in apoptosis), NES (nestin, a neural stem cell marker), GAP43 (growth-associated protein 43, essential for synaptic remodeling), APOE (apolipoprotein E, associated with Alzheimer’s disease risk), SOD2 (superoxide dismutase 2, a mitochondrial antioxidant enzyme), PPARA and PPARG (peroxisome proliferator-activated receptors, involved in inflammation and metabolism), GPX1 (glutathione peroxidase 1, an antioxidant enzyme), and CALM1 (calmodulin 1, central to calcium signaling) [7, 8, 14].
Is Pinealon approved for human use?
Pinealon is not approved by the FDA or equivalent regulatory agencies as a pharmaceutical drug for human use. All Pinealon products sold by Iron Peak Peptides are intended strictly for laboratory research purposes only and are not for human consumption. Researchers should consult applicable local regulations regarding the purchase and use of research peptides in their jurisdiction.
What concentrations have been used in published Pinealon research?
Published studies have used varying concentrations depending on the experimental system. In vitro cell culture studies have typically employed concentrations in the nanomolar to low micromolar range. In vivo animal studies have used intraperitoneal doses of 10 μg/kg (in the prenatal hyperhomocysteinemia model) [4] and 400 μg/kg (in the 5xFAD Alzheimer’s model) [8]. These concentrations are reported for informational reference regarding published research protocols and are not intended as dosage recommendations.
References
Khavinson VK. Peptides and ageing. Neuroendocrinology Letters. 2002;23(Suppl 3):11-144. PMID: 12374906.
Khavinson VK, Kuznik BI, Ryzhak GA. Peptide bioregulators: a new class of geroprotectors. Message 1. Results of experimental studies. Advances in Gerontology. 2013;3(3):225-235. PMID: 23734519.
Khavinson V, Ribakova Y, Kulebiakin K, Vladychenskaya E, Kozina L, Arutjunyan A, Boldyrev A. Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes. Rejuvenation Research. 2011;14(5):535-541. doi: 10.1089/rej.2011.1172. PMID: 21978084.
Arutjunyan A, Kozina L, Stvolinskiy S, Bulygina Y, Mashkina A, Khavinson V. Pinealon protects the rat offspring from prenatal hyperhomocysteinemia. International Journal of Clinical and Experimental Medicine. 2012;5(2):179-185. PMID: 22567179.
Khavinson VK, Linkova NS, Tarnovskaya SI. Short peptides regulate gene expression. Bulletin of Experimental Biology and Medicine. 2016;162(2):288-292. doi: 10.1007/s10517-016-3596-7. PMID: 27909961.
Khavinson V, Popovich I. Peptide regulation of gene expression: a systematic review. Molecules. 2021;26(22):7053. doi: 10.3390/molecules26227053. PMID: 34834147.
Khavinson V, Linkova N, Kozhevnikova E, Trofimova S. EDR peptide: possible mechanism of gene expression and protein synthesis regulation involved in the pathogenesis of Alzheimer’s disease. Molecules. 2020;26(1):159. doi: 10.3390/molecules26010159. PMID: 33396470.
Khavinson V, Ilina A, Kraskovskaya N, Linkova N, Kolchina N, Mironova E, Erofeev A, Petukhov M. Neuroprotective effects of tripeptides—epigenetic regulators in mouse model of Alzheimer’s disease. Pharmaceuticals. 2021;14(6):515. doi: 10.3390/ph14060515. PMID: 34071923.
Khavinson VKh, Linkova NS, Tarnovskaya SI, Umnov RS. Short peptides stimulate serotonin expression in cells of brain cortex. Bulletin of Experimental Biology and Medicine. 2014;157(1):77-80. doi: 10.1007/s10517-014-2496-y. PMID: 24909721.
Khavinson VK, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuroendocrinology Letters. 2003;24(3-4):233-240. PMID: 14523363.
Khavinson VK. Peptide bioregulation of aging: results and prospects. Biogerontology. 2009;10(4):401-407. doi: 10.1007/s10522-008-9213-2. PMID: 19830585.
Fedin AI, Belskaya GN, Kurushina OV, et al. Dose-dependent effects of cortexin in chronic cerebral ischemia (results of a multicenter randomized controlled study). S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(9):35-42. doi: 10.17116/jnevro201811809135. PMID: 30335070.
Khavinson V, Linkova N, Kukanova E, et al. Neuroprotective effect of EDR peptide in mouse model of Huntington’s disease. Journal of Neurology and Neuroscience. 2017;8(1):166. doi: 10.21767/2171-6625.1000166.
Ilina A, Khavinson V, Linkova N, Petukhov M. Neuroepigenetic mechanisms of action of ultrashort peptides in Alzheimer’s disease. International Journal of Molecular Sciences. 2022;23(8):4259. doi: 10.3390/ijms23084259. PMID: 35457084.
Khavinson V, Popovich I. Short peptides regulate gene expression, protein synthesis and enhance life span. In: Anti-aging Drugs: From Basic Research to Clinical Practice. RSC Drug Discovery Series. 2017:496-513.
Khavinson V, Linkova N, Dyatlova A, et al. Short peptides protect fibroblast-derived induced neurons from age-related changes. International Journal of Molecular Sciences. 2024;25(21):11363. doi: 10.3390/ijms252111363.
Anisimov VN, Khavinson VK, Popovich IG, et al. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology. 2003;4(4):193-202. doi: 10.1023/a:1025114230714. PMID: 14501183.
Khavinson VK, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bulletin of Experimental Biology and Medicine. 2003;135(6):590-592. doi: 10.1023/a:1025493705728. PMID: 12937682.
Anisimov VN, Khavinson VK. Pineal peptides as modulators of aging. Aging (Milano). 1995;7(4):294-298. doi: 10.1007/BF03324346. PMID: 8580589.
Kozina LS, Arutjunyan AV, Stvolinski SL, Stepanova MS, Makletsova MG, Khavinson VK. Regulatory peptides protect brain neurons from hypoxia in vivo. Doklady Biological Sciences. 2008;418(1):1-4. doi: 10.1134/S0012496608010031. PMID: 21249538.
Kozina LS, Arutjunyan AV, Stvolinski SL, Khavinson VK. Biological activity of regulatory peptides in model experiments in vitro. Advances in Gerontology. 2008;21(1):68-73. PMID: 18546826.
Linkova NS, Khavinson VK, Kozhevnikova EO, Trofimova SV. Peptide regulation of chondrogenesis and osteogenesis during aging. Cell and Tissue Biology. 2016;10(3):166-174. doi: 10.1134/S1990519X16030068.
Khavinson VK, Kuznik BI, Ryzhak GA. Peptide bioregulators: a new class of geroprotectors, report 2. The results of clinical trials. Advances in Gerontology. 2014;4(4):346-361.
Boldyrev AA, Carpenter DO, Johnson P. Emerging evidence for a similar role of glutamate receptors in the nervous and immune systems. Journal of Neurochemistry. 2005;95(4):913-918. doi: 10.1111/j.1471-4159.2005.03456.x. PMID: 16092928.
Makhro AV, Mashkina AP, Solenaya OA, Trunova OA, Kozina LS, Arutjunyan AV, Bulygina ER. Prenatal hyperhomocysteinemia as a model of oxidative stress in the brain. Bulletin of Experimental Biology and Medicine. 2008;146(1):33-35. doi: 10.1007/s10517-008-0233-0. PMID: 19145343.
All products mentioned in this article are sold strictly for laboratory and research purposes only. Not for human consumption. Consult applicable regulations in your jurisdiction before purchasing research materials. The information provided here is for educational and informational purposes and does not constitute medical advice, diagnosis, or treatment recommendations.
Related Research
🔬 Explore Research Peptides
- Glutathione 1500mg — $59.00
- DSIP 5mg — $40.00
- AOD-9604 5mg — $44.99
- TB-500 10mg — $69.99
